Immunomanipulative strategies for the control of human papillomavirus associated cervical disease

Immunologic Research
R W Tindle

Abstract

Three vaccine strategies that target human papillomavirus (HPV) are likely to be effective in the control of HPV-associated preneoplastic and neoplastic lesions of the uterine cervix. 1. Immunotherapy for HPV-associated cervical cancer targeted at two nonstructural PV proteins expressed in cancer cells (E6 and E7). 2. Vaccines against existing HPV infection and early premalignant lesions targeted at early viral proteins expressed in suprabasal stem cells of infected anogenital epithelium. 3. Prophylactic vaccines to prevent HPV infection involving immunization with genetically engineered virus-like particles to elicit neutralizing antibody. Strategies 1 and 2 will need to evoke cytotoxic T-cell (CTL) mediated responses.

References

Mar 1, 1979·The Journal of Experimental Medicine·C O ElsonW Strober
Jan 1, 1992·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A AltmannS C Meuer
Jan 1, 1992·Mammalian Genome : Official Journal of the International Mammalian Genome Society·T KoizumiJ H Nadeau
Jan 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·L P ChenK E Hellström
Jun 1, 1988·International Journal of Dermatology·T T RogozinskiM Jarzabek-Chorzelska
Nov 1, 1987·Veterinary Pathology·C L BregmanE F Christensen
Dec 1, 1986·The British Journal of Dermatology·R RüdlingerJ A Hunter
Nov 1, 1994·Journal of Virology·R B RodenJ T Schiller
Jun 20, 1995·Proceedings of the National Academy of Sciences of the United States of America·S A ThomsonA Suhrbier
Nov 1, 1994·Journal of Virology·R B RodenJ T Schiller
Jun 7, 1994·Proceedings of the National Academy of Sciences of the United States of America·R J SlebosK R Cho
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·E F FynanH L Robinson
Feb 1, 1993·Journal of Clinical Microbiology·L DillnerJ Dillner
Jun 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·P F LambertA E Griep
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·J A SuzichR Schlegel
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·T C WuD M Pardoll

❮ Previous
Next ❯

Citations

Jul 7, 1999·Neuroscience and Biobehavioral Reviews·K VedharaE C Wang
Aug 2, 2002·Expert Opinion on Investigational Drugs·Christine Armbruster
Nov 4, 2000·Expert Opinion on Investigational Drugs·K A Alexander, W C Phelps
Apr 25, 2003·American Journal of Obstetrics and Gynecology·Ellen E SheetsPeggy A Crowley-Nowick
Mar 12, 2002·Virology·Nico MichelMartin Müller
Nov 25, 2004·International Journal of Health Services : Planning, Administration, Evaluation·Peter Crampton, Barbara Starfield
Jan 12, 2008·Journal of Psychiatric and Mental Health Nursing·W J Yen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.